期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 60, 期 18, 页码 1722-1732出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2012.01.086
关键词
atrial septal defect; patent foramen ovale; percutaneous closure
Percutaneous treatment of inter-atrial septal defects has undergone exponential growth in the past 2 decades. Improved percutaneous devices and interventional techniques with low complication rates make this procedure an attractive therapeutic option for congenital atrial septal defects (ASD). Although indications for catheter-based ASD closure are well-documented, those for catheter-based patent foramen ovale (PFO) closure are still evolving. Results from 2 randomized clinical trials question the benefit of percutaneous PFO closure, but concern has also been raised about the efficacy of the device used in those trials. This review will focus on the anatomy, associated syndromes, detection, and data for percutaneous closure of both PFOs and ASDs. (J Am Coll Cardiol 2012;60:1722-32) (C) 2012 by the American College of Cardiology Foundation
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据